Reasons for IVF Failure and What to Do Next
A clinical guide to reviewing an unsuccessful IVF cycle and considering medically appropriate next steps
Why an IVF cycle may not lead to pregnancy
A negative beta-hCG result after an IVF cycle can bring disappointment, grief, confusion and physical exhaustion. You may find yourself reviewing each stage of treatment and asking, “Why did my IVF cycle fail?” These reactions are understandable. An unsuccessful cycle is not a personal failure, and you do not need to make an immediate decision about another cycle.
IVF involves several stages: ovarian stimulation, egg collection, fertilisation, embryo development, embryo transfer and implantation. A difficulty at one or more stages may affect the outcome. Sometimes the clinical records point to a possible contributing factor; in other cases, current tests cannot identify one definite explanation.
One unsuccessful embryo transfer does not, by itself, establish recurrent implantation failure or show that pregnancy cannot occur. A clinician should interpret the result in the context of age, diagnosis, ovarian response, embryo development, transfer details and previous treatment history. A structured review may help determine whether the previous approach remains appropriate, whether a specific issue needs assessment, or whether no change is justified.
Possible medical factors associated with an unsuccessful IVF cycle
1. Embryo development and chromosome differences
An embryo may look well-developed under a microscope and still have an abnormal number of chromosomes. This is called aneuploidy. Chromosome differences can affect implantation or further embryo development. The frequency of these differences generally increases with maternal age, but age alone cannot predict the outcome of an individual embryo.
Embryo grading describes visible features such as cell appearance, fragmentation and expansion. It does not confirm that an embryo has a normal chromosome complement. An embryo with a favourable morphological grade may therefore still fail to implant.
Blastocyst culture allows the embryology team to observe embryos for longer, usually until Day 5 or Day 6. Extended culture may help with embryo selection in selected circumstances, but not every embryo reaches the blastocyst stage in the laboratory. Day 3 transfer may also be considered in selected cases, including when embryo numbers are limited or the clinical team considers earlier transfer appropriate.
Preimplantation genetic testing for aneuploidy (PGT-A) examines a small sample of cells from a blastocyst for chromosome-number differences. A specialist may discuss it in selected clinical situations after explaining its limitations, cost, the possibility that no embryo will be suitable for transfer, and the fact that it does not guarantee pregnancy. It should not be presented as a routine solution for every unsuccessful IVF cycle.
2. Uterine cavity, endometrium and implantation timing
The uterine cavity and endometrium are among the factors clinicians consider when reviewing an embryo transfer. Ultrasound may assess endometrial thickness and pattern, but thickness alone does not fully measure endometrial function or predict implantation.
Uterine polyps, submucosal fibroids, intrauterine adhesions or some uterine structural differences may be relevant in selected cases. Hydrosalpinx may also affect IVF planning. A clinician may consider chronic endometritis assessment when the history or findings raise suspicion; diagnostic methods and evidence vary, so testing should follow an individual clinical rationale.
The implantation window describes the period when the endometrium is receptive to an embryo. Its timing is considered alongside progesterone exposure and the transfer protocol. Commercial endometrial receptivity tests are not established as routine investigations for everyone after an unsuccessful transfer. A specialist should explain the uncertainty around their clinical value before recommending one.
3. Sperm-related factors and fertilisation
A semen analysis assesses sperm concentration, movement and shape. It is an important part of male fertility assessment, but it does not measure every aspect of sperm function or DNA integrity.
Sperm DNA fragmentation refers to breaks or damage in sperm genetic material. Its relevance depends on the individual clinical context. Testing is not a routine explanation for every unsuccessful embryo transfer; a specialist may consider it in selected situations, based on the couple’s history and other findings.
Intracytoplasmic sperm injection (ICSI) involves injecting a single sperm into a mature egg. It may be appropriate for specific indications, such as significant sperm abnormalities or previous fertilisation problems, but it is not automatically required after every unsuccessful IVF cycle. Surgical sperm retrieval may be considered when sperm are absent from the ejaculate and the clinical assessment supports that approach.
Related information: ICSI (Intracytoplasmic Sperm Injection)
4. Ovarian response and stimulation planning
Ovarian stimulation aims to obtain an appropriate number of mature eggs while limiting treatment risks. Some patients develop fewer follicles or mature eggs than expected. Others respond strongly and may need a different approach to reduce the risk of ovarian hyperstimulation syndrome (OHSS).
A future cycle may involve a change in medication dose, stimulation schedule, monitoring plan or protocol. No single protocol suits everyone. Decisions should take account of age, ovarian reserve markers, antral follicle count, previous response, diagnosis and safety.
Related information: Ovarian reserve testing: AMH and AFC
5. Embryology laboratory and embryo-transfer factors
Embryo development in the laboratory depends on controlled conditions, including temperature, gas levels, air quality, culture-media handling and equipment performance. A laboratory review should rely on documented monitoring and quality-control records rather than assumptions.
A cycle review may consider the fertilisation method, fertilisation findings, embryo development, culture observations, freezing and thawing records, and any technical issues recorded by the laboratory. The team may also review transfer technique, catheter passage, ultrasound guidance and progesterone timing. These factors should be assessed from the actual records; a patient should not be told that a laboratory or transfer issue caused the outcome without supporting evidence.
What to review before deciding on another IVF cycle
Step 1: Review the complete treatment record
Ask for an explanation of the stimulation chart, hormone results, follicle growth, number of eggs collected, number of mature eggs, fertilisation findings and embryo development. If you had an embryo transfer, the review may also include embryo stage and grade, fresh or frozen transfer, endometrial assessment, progesterone timing, transfer notes and the beta-hCG result.
- How many eggs were collected, and how many were mature?
- How many eggs fertilised, and which fertilisation method did the team use?
- How did the embryos develop on Day 3 and, if cultured, on Day 5 or Day 6?
- What do the embryo grading and laboratory records show?
- Did the transfer record mention any technical difficulty?
- What luteal-phase support did the team prescribe, and were there any concerns about timing or use?
The purpose of this discussion is to understand what the records show, what remains uncertain and whether any change has a clear clinical basis.
Step 2: Assess the uterus only when indicated
A transvaginal ultrasound, saline-infusion sonography or 3D ultrasound may help assess the uterine cavity and pelvic structures. Diagnostic hysteroscopy allows direct visual examination of the uterine cavity. A clinician may use it to investigate or treat selected findings, such as adhesions or a cavity-distorting polyp or fibroid.
Hysteroscopy is not a routine add-on that every patient needs before another IVF cycle. It is more appropriate when symptoms, imaging or treatment history suggest a uterine-cavity concern. Laparoscopy is also not a routine test after IVF failure; a clinician may consider it when there is a separate suspicion, such as endometriosis, pelvic adhesions or another pelvic condition that could change management.
Related information: Diagnostic hysteroscopy and laparoscopy
Step 3: Review stimulation and frozen-transfer planning
The next stimulation plan, if another cycle is appropriate, should reflect the previous ovarian response and the patient’s medical history. The treating team may review medication type or dose, monitoring frequency and trigger strategy. For frozen embryo transfer, the team may discuss a natural, modified-natural or medicated cycle according to ovulation pattern, endometrial development and clinical history.
Progesterone and other luteal-support medicines should follow the prescribed transfer protocol. Do not start, stop or change fertility medicines without speaking to the treating team.
Step 4: Discuss embryology options only when relevant
Depending on embryo numbers and development, the embryology team may discuss Day 3 transfer or extended culture to Day 5 or Day 6. Blastocyst culture can support embryo selection when several embryos are available, but extended culture may also result in no blastocyst being available for transfer. The decision should reflect the individual cycle rather than a general claim that one transfer day is always better.
ICSI may be appropriate for specific sperm-related or fertilisation indications. Surgical sperm retrieval may be discussed in selected cases of azoospermia. PGT-A may be considered after counselling in selected clinical situations; it should not be described as a guaranteed solution to implantation failure.
First-cycle review: records and possible next discussions
| Records to Review | Possible Discussion, if Clinically Indicated |
|---|---|
| Semen analysis and fertilisation record | Review sperm-related factors and fertilisation history; consider additional male-factor assessment only when justified. |
| Embryo grading and transfer-day report | Discuss Day 3 versus Day 5/6 culture in light of embryo numbers, development and clinical context. |
| Ultrasound report and endometrial assessment | Consider further cavity imaging or hysteroscopy if symptoms or findings suggest an abnormality. |
| Stimulation chart, hormone results and egg maturity | Review medication, protocol, monitoring or trigger planning according to ovarian response and safety. |
| Progesterone prescription and transfer timing | Review luteal support and the timing and type of frozen-transfer preparation. |
| Relevant personal and family history | Consider genetic counselling or testing only when the history and clinical indication support it. |
| Embryology and laboratory records | Review documented culture, freezing/thawing and quality-control information with the embryology team. |
Frequently asked questions
Pregnancy may occur in a later cycle, but the likelihood depends on factors such as age, embryo availability and development, the underlying diagnosis, uterine findings and previous treatment details. After repeated unsuccessful transfers, ask for an individualised review. Do not assume that another cycle or a particular add-on will produce a specific result.
There is no single waiting period for everyone. Timing depends on the type of cycle, whether it involved a fresh or frozen transfer, any pregnancy loss, ovarian hyperstimulation risk, physical recovery and the need for further investigations. The treating specialist can advise when another cycle is medically appropriate.
No. One cycle cannot establish that egg quality is permanently poor. Egg number and maturity may vary between cycles, and embryo development depends on several factors. Age, ovarian reserve assessment and the full cycle record provide more context than one result alone.
Hysteroscopy may be considered when symptoms, imaging or medical history suggest a uterine-cavity concern, such as adhesions, a polyp or a submucosal fibroid. Laparoscopy is generally reserved for a suspected pelvic condition, such as endometriosis or adhesions, when the findings could change management. Neither procedure is automatically required after every unsuccessful IVF cycle.
No. Blastocyst culture may help with embryo selection when enough embryos are available, but some embryos may not reach Day 5 or Day 6. Day 3 transfer may be appropriate in selected cases. The embryologist and fertility specialist should explain the advantages and limitations for the individual cycle.
A considered approach after an unsuccessful IVF cycle
If an IVF cycle did not result in pregnancy, the available records can help explain what happened during treatment, although they may not identify one definite cause. A careful review can clarify whether further assessment is warranted, whether the previous protocol matched the clinical situation and whether any proposed change has a sound medical basis.
Patients may wish to request copies of their treatment records and prepare questions before a follow-up discussion. Decisions about additional tests, procedures, medicines or another cycle should follow an individual assessment and informed discussion with a qualified fertility specialist. No investigation or treatment can guarantee pregnancy.
About the author
Dr. Monika Sharma (MBBS, MS – OBG) is an obstetrician and gynaecologist with clinical experience in women’s health and reproductive medicine. Her work includes the assessment and management of fertility-related concerns, with an emphasis on evidence-based clinical guidance.
Important medical information
This article provides general educational information. It does not replace an individual consultation, diagnosis or treatment plan. Not every test or intervention discussed here is suitable for every patient. Decisions about PGT-A, hysteroscopy, laparoscopy, sperm DNA fragmentation testing, ICSI and endometrial receptivity assessment should follow a qualified clinician’s review of the medical history, examination findings and available evidence.
Comments are closed